THC Therapeutics, Inc. reported earnings results for the second quarter and six months ended January 31, 2022. For the second quarter, the company reported net loss was USD 0.75246 million compared to USD 0.359825 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.02 a year ago.
For the six months, net loss was USD 1.24 million compared to USD 0.449875 million a year ago. Basic loss per share from continuing operations was USD 0.04 compared to USD 0.02 a year ago.